Jiri Mestecky
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jiri Mestecky has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Michael W. Russell
Department of Microbiology and Immunology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, United States
2 shared publications Charles R. Wira
Department of Physiology, Dartmouth Medical School, Lebanon, New Hampshire
1 shared publication- Charlotte Slayton Kaetzel
Department of Microbiology, Immunology & Molecular Genetics, University of Kentucky College of Medicine, Lexington, Kentucky, USA
1 shared publication - David Moylan
Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
1 shared publication - Holly Elizabeth Richter
University of Alabama at Birmingham
1 shared publication Jenny M. Woof
1 shared publication
Latest Publications
- Open Access
- 16 October 2024
- Published by American Society for Microbiology in mBio
- Vol. 15 (10) , e0083324
Role of IgA1 protease-producing bacteria in SARS-CoV-2 infection and transmission: a hypothesis
Secretory (S) IgA antibodies against severe acute respiratory syndrome (SARS)-CoV-2 are induced in saliva and upper respiratory tract (URT) secretions by natural infection and may be critical in determining the outcome of initial infection. Secretory IgA1 (SIgA1) is the predominant isotype of antibodies in these secretions. Neutralization of SARS-CoV-2 is most effectively accomplished by polymeric antibodies such as SIgA. We hypothesize that cleavage of SIgA1 antibodies against SARS-CoV-2 by unique bacterial IgA1 proteases to univalent Fabα antibody fragments with diminished virus neutralizing activity would facilitate the descent of the virus into the lungs to cause serious disease and also enhance its airborne transmission to others. Recent studies of the nasopharyngeal microbiota of patients with SARS-CoV-2 infection have revealed significant increases in the proportions of IgA1 protease-producing bacteria in comparison with healthy subjects. Similar considerations might apply also to other respiratory viral infections including influenza, possibly explaining the original attribution of influenza to Haemophilus influenzae , which produces IgA1 protease.
- 16 October 2024
- Published by American Society for Microbiology in mBio
- Vol. 15 (10) , e0083324
Open AccessRole of IgA1 protease-producing bacteria in SARS-CoV-2 infection and transmission: a hypothesis
Secretory (S) IgA antibodies against severe acute respiratory syndrome (SARS)-CoV-2 are induced in saliva and upper respiratory tract (URT) secretions by natural infection and may be critical in determining the outcome of initial infection. Secretory IgA1 (SIgA1) is the predominant isotype of antibodies in these secretions. Neutralization of SARS-CoV-2 is most effectively accomplished by polymeric antibodies such as SIgA. We hypothesize that cleavage of SIgA1 antibodies against SARS-CoV-2 by unique bacterial IgA1 proteases to univalent Fabα antibody fragments with diminished virus neutralizing activity would facilitate the descent of the virus into the lungs to cause serious disease and also enhance its airborne transmission to others. Recent studies of the nasopharyngeal microbiota of patients with SARS-CoV-2 infection have revealed significant increases in the proportions of IgA1 protease-producing bacteria in comparison with healthy subjects. Similar considerations might apply also to other respiratory viral infections including influenza, possibly explaining the original attribution of influenza to Haemophilus influenzae , which produces IgA1 protease.
- 21 April 2020
- Published by Taylor & Francis
- p. 151-170
Secretory immunoglobulins and their transport
The early demonstration of the presence of antibodies in external secretions of the gastrointestinal tract and later in milk, saliva, tears, respiratory and genital tract secretions, and urine stimulated extensive studies of their structure, function, and induction following immunization. In contrast to plasma, external secretions contain lower levels and a markedly different immunoglobulin (Ig) isotype distribution of antibodies with characteristic structural and functional properties. Igs of all isotypes are present in external secretions; however, their relative distribution and molecular forms display marked differences in comparison with plasma. All isotypes of Igs are present in external secretions, albeit at markedly different concentrations. The transport of polymeric Igs across mucosal epithelial cells is mediated by a transmembrane glycoprotein called the polymeric Igreceptor. In humans and several other species, the production of IgA far exceeds the combined synthesis of all other isotypes of Igs. Humans and other primates have evolved a distinct pathway for transport of secretory antibodies into bile.
- 21 April 2020
- Published by Taylor & Francis
- p. 151-170
Secretory immunoglobulins and their transport
The early demonstration of the presence of antibodies in external secretions of the gastrointestinal tract and later in milk, saliva, tears, respiratory and genital tract secretions, and urine stimulated extensive studies of their structure, function, and induction following immunization. In contrast to plasma, external secretions contain lower levels and a markedly different immunoglobulin (Ig) isotype distribution of antibodies with characteristic structural and functional properties. Igs of all isotypes are present in external secretions; however, their relative distribution and molecular forms display marked differences in comparison with plasma. All isotypes of Igs are present in external secretions, albeit at markedly different concentrations. The transport of polymeric Igs across mucosal epithelial cells is mediated by a transmembrane glycoprotein called the polymeric Igreceptor. In humans and several other species, the production of IgA far exceeds the combined synthesis of all other isotypes of Igs. Humans and other primates have evolved a distinct pathway for transport of secretory antibodies into bile.
- Open Access
- 15 September 2016
- Published by Case Western Reserve University in Pathogens and Immunity
- Vol. 1 (2) , 371-389
Diminished CD103 (aEb7) Expression on Resident T cells from the Female Genital Tract of HIV-positive women
Background:Tissue resident memory T cells (TrM) provide an enhanced response against infection at mucosal surfaces, yet their function has not been extensively studied in humans, including the female genital tract (FGT).Methods: Using polychromatic flow cytometry, we studied TrM cells, defined as CD62L-CCR7-CD103+CD69+ CD4+ and CD8+ T cells in mucosa-derived T cells from healthy and HIV-positive women.Results: We demonstrate that TrM are present in the FGT of healthy and HIV-positive women. The expression of the mucosal retention receptor, CD103, from HIV-positive women was reduced compared to healthy women and was lowest in women with CD4 counts < 500 cells/mm3. Furthermore, CD103 expression on mucosa-derived CD8+ T cells correlated with antigen-specific IFN-γ production by mucosal CD4+ T cells and was inversely correlated with T-bet from CD8+CD103+ mucosa-derived T cells.Conclusions: These data suggest that CD4+ T cells, known to be impaired during HIV-1 infection and necessary for the expression of CD103 in murine models, may play a role in the expression of CD103 on resident T cells from the human FGT.
- 15 September 2016
- Published by Case Western Reserve University in Pathogens and Immunity
- Vol. 1 (2) , 371-389
Open AccessDiminished CD103 (aEb7) Expression on Resident T cells from the Female Genital Tract of HIV-positive women
Background:Tissue resident memory T cells (TrM) provide an enhanced response against infection at mucosal surfaces, yet their function has not been extensively studied in humans, including the female genital tract (FGT).Methods: Using polychromatic flow cytometry, we studied TrM cells, defined as CD62L-CCR7-CD103+CD69+ CD4+ and CD8+ T cells in mucosa-derived T cells from healthy and HIV-positive women.Results: We demonstrate that TrM are present in the FGT of healthy and HIV-positive women. The expression of the mucosal retention receptor, CD103, from HIV-positive women was reduced compared to healthy women and was lowest in women with CD4 counts < 500 cells/mm3. Furthermore, CD103 expression on mucosa-derived CD8+ T cells correlated with antigen-specific IFN-γ production by mucosal CD4+ T cells and was inversely correlated with T-bet from CD8+CD103+ mucosa-derived T cells.Conclusions: These data suggest that CD4+ T cells, known to be impaired during HIV-1 infection and necessary for the expression of CD103 in murine models, may play a role in the expression of CD103 on resident T cells from the human FGT.
- 21 November 2005
- Published by Springer Nature
- p. 57-68
Diagnostic Significance of Antibodies in Oral Secretions
- 21 November 2005
- Published by Springer Nature
- p. 57-68
Diagnostic Significance of Antibodies in Oral Secretions
- 1 January 2005
- Published by Elsevier
- p. 1631-1646
Mucosal Immunity in the Human Female Reproductive Tract
- 1 January 2005
- Published by Elsevier
- p. 1631-1646
Mucosal Immunity in the Human Female Reproductive Tract